Pharmacogenetic Test

Preferred Label : Pharmacogenetic Test;

Alternative definition : FDA: An assay intended to study interindividual variations in DNA sequence related to drug absorption and disposition (pharmacokinetics) or drug action (pharmacodynamics), including polymorphic variation(s) in the genes that encode the functions of transporters, metabolizing enzymes, receptors, and other proteins. From: Pharmacogenomic Data Submissions, FDA Guidance for Industry; CDISC-GLOSS: An assay intended to study interindividual variations in DNA sequence related to drug absorption and disposition or drug action. Compare to pharmacogenomic test.;

Details

Origin ID

C68761;

UMLS CUI

C2347500;

Automatic exact mappings (from CISMeF team)
- Pharmacogenomic Testing [MeSH Descriptor]
Semantic type(s)
- Laboratory Procedure [UMLS semantic type]
concept_is_in_subset
- CDISC Glossary Terminology [NCIt concept]
- CTRP Intervention Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- Clinical Data Interchange Standards Consortium Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients